Press Release: Digital Summit 2026 Spotlights Life Sciences Shift From AI Promise to Performance

Indegene shared a press release on its Digital Summit 2026, held 22 September 2026 in Philadelphia.

Tue 6 Oct 2026

Pharma Attendees

120+ pharma attendees

Summit Content

19 speakers, 4 keynotes, 8 panels, 410+ minutes of sessions

Participation Growth

40% more pharma participation than 2025

From promise to performance

Indegene shared a press release on its Digital Summit 2026 (IDS 2026), held on 22 September 2026 at the National Constitution Center, Philadelphia. This release is shared in addition to a press release titled "From Promise to Performance: Life Sciences Leaders Focus on Operationalizing AI to Deliver Enterprise Outcomes at Indegene Digital Summit 2026" shared with the exchanges on 23 September 2026.

The theme of the release is how life sciences leaders are moving from experimenting with AI to applying it at enterprise scale.

What the summit included

• 4 keynotes and 8 panels and presentations
• 410+ minutes of sessions
• 19 speakers, with 40% more pharma participation than 2025
• 120+ pharma attendees, of whom 50%+ were decision makers and sponsors
• 120+ senior pharma leaders, of whom 50% were decision makers and 70% were Director+

The release names the keynote speakers as David Shulkin (Ninth Secretary, U.S. Department of Veterans Affairs), Amol Punjabi (Chief Product Officer, OpenEvidence), Agam Upadhyay (Chief Digital & Information Officer, Vertex) and Corinne Le Goff (Chief Commercial Officer, Viatris).

Broadening the audience

The release describes the summit as attracting voices that influence healthcare policy, AI adoption and enterprise transformation, grouped as industry leaders (commercial, medical, digital, data and technology executives), external catalysts (AI innovators, policymakers and thought leaders), and strategic topics covering AI operating models, customer engagement, enterprise transformation and the future of work.

It states that attendees represented commercial, medical, digital, technology and enterprise leadership roles, and that participation came from both large pharma and emerging biopharma companies. It also frames the event as moving from an industry participant to an industry convenor, listing pharma CEOs and commercial leaders, digital and technology leaders, AI innovators, former policymakers and government leaders, and industry analysts and researchers.

AI in focus

The release says the summit worked to shift the industry conversation from "How can AI work in Pharma?" to "How do we operationalize AI at scale?", and states that 8 sessions explored the impact and performance of AI from industry, leader and capability points of view.

It describes an Indegene AI Experience Zone, presented as moving from isolated capability kiosks in previous years to an integrated end-to-end experience across three stages: imagine at speed (powered by Agentic AOR), create at scale (powered by Content Super App) and engage with precision (powered by Audience IQ (Tandem)).

The release also refers to the Vital Awards, described as recognising leaders driving measurable impact across healthcare.

What it signals

The release lists four signals

• For the industry: a shift from AI experimentation to enterprise transformation
• For clients: a trusted platform to exchange ideas and accelerate change
• For Indegene: growing influence as a strategic partner, AI innovator and industry convenor
• For investors: evidence that Indegene's investments in AI, platforms, domain expertise and ecosystem leadership are strengthening its strategic position within life sciences

Key takeaways listed from the summit

• AI success depends on reimagined operating models, not technology alone
• Customer attention is shifting toward AI-mediated discovery and evidence-led engagement
• Governance, workflow redesign and business ownership are becoming critical for enterprise scale
• Agile organizations will outperform by combining human expertise, AI intelligence and continuous learning
• The next competitive advantage in life sciences will come from turning AI capability into measurable business performance

The release also states that the Philadelphia venue reinforced the summit's focus on leadership, transformation and the future of life sciences, and that the event strengthened executive engagement across the U.S. life sciences ecosystem, with a premium executive experience including the "Freedom Rising Show" and other experience zones enabling deeper engagement with existing and prospective clients.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.